My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

iShares Biotechnology ETF (NQ:IBB)

168.88 -0.01 (-0.01%)

Streaming Delayed Price Updated: 3:56 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock ↗

December 29, 2025

Via Stocktwits

Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet ↗

December 26, 2025

After a strong biotech rebound, one fund quietly walked away from sector beta, and the timing says more than the trade itself.

Via The Motley Fool

Topics ETFs Regulatory Compliance

Moderna And Super Micro Top S&P 500 Short Interest List — Are They Ripe For A Squeeze? ↗

December 11, 2025

Investors remain divided on Moderna and Super Micro as heavy short interest reflects skepticism, yet recent catalysts suggest both names could still deliver unpredictable, sentiment-driven swings.

Via Stocktwits

Topics Artificial Intelligence Stocks

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

December 01, 2025

Via MarketBeat

White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report ↗

September 26, 2025

Via Stocktwits

CDC Turmoil Escalates: Kennedy To Testify In Senate After Director Fired, Senior Officials Quit ↗

August 28, 2025

Via Stocktwits

CDC Chief Susan Monarez Pushed Out After Weeks On Job As RFK Jr. Overhauls Agency — She’s Fighting Back ↗

August 27, 2025

Via Stocktwits

Clean Energy’s Second Wind: What iShares Global Clean Energy ETF Tells Us Now ↗

November 11, 2025

Clean Energy’s Second Wind: What iShares Global Clean Energy ETF Tells Us Now

Via The Motley Fool

Topics Derivatives ETFs Regulatory Compliance

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals ↗

November 03, 2025

Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals

Via The Motley Fool

Topics ETFs Regulatory Compliance

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗

November 03, 2025

Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025.

Via Benzinga

Topics ETFs

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗

October 27, 2025

Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.

Via Benzinga

SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗

October 15, 2025

SciSparc traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures.

Via Benzinga

Enpro Moves To Boost Profits With $280 Million Acquisition Push ↗

October 13, 2025

Enpro Inc. (NYSE: NPO) acquiring AlpHa Measurement Solutions and Overlook Industries for $280 million in cash.

Via Benzinga

Financial Markets Signal Near 100% Probability of Fed Rate Cut: What it Means for the Economy and Investors

October 09, 2025

The financial markets are currently flashing a near 100% probability of a Federal Reserve interest rate cut at the upcoming October 28-29 Federal Open Market Committee (FOMC) meeting. This overwhelming...

Via MarketMinute

Topics Bonds Credit Cards Economy

Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging ↗

October 07, 2025

Via The Motley Fool

Topics Artificial Intelligence ETFs Regulatory Compliance

How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline ↗

October 07, 2025

Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' radar as Washington's shutdown drags on.

Via Benzinga

Topics ETFs Government

SciSparc And AutoMax Call Off Merger ↗

October 06, 2025

SciSparc ends merger with AutoMax, sets loan repayment terms, and refocuses on CNS drug development and innovation.

Via Benzinga

Dallas Fed President Lorie Logan Warns Against Premature Rate Cuts, Prioritizing Inflation Fight

October 03, 2025

Federal Reserve Bank of Dallas President Lorie Logan delivered a stark warning on October 2nd and reiterated it today, October 3rd, 2025, emphasizing the paramount importance of tackling persistent...

Via MarketMinute

Topics Bonds Credit Cards Economy

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

President Donald Trump threatened 100% tariffs on some drug imports.

Via Investor's Business Daily

Topics ETFs Government World Trade

Small Cap Revival: Could Rate Cuts Spark a Rebound in Smaller Companies?

September 17, 2025

As whispers of impending interest rate cuts grow louder from central banks worldwide, a new wave of optimism is beginning to ripple through the often-overlooked small-cap sector. These nimble,...

Via MarketMinute

Topics Economy

Biotech Sector May Flip to Market Leader by Year-End ↗

September 15, 2025

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

Via MarketBeat

Topics ETFs Economy Stocks

Trump's Biotech Playbook Ignites $350 Billion Investment Blitz ↗

September 09, 2025

Trump's policies have sparked a $350B investment surge in US biotech, creating job & revenue opportunities. Investors can track with XBI or IBB ETFs and consider JNJ, NVS, LLY, AZN, BMY as potential...

Via Benzinga

Topics ETFs Government

FDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The Market ↗

July 18, 2025

The FDA had already been investigating two earlier deaths linked to Elevidys.

Via Stocktwits

Topics Death

Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn ↗

July 16, 2025

President Donald Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month.

Via Investor's Business Daily

Topics ETFs Government World Trade

Trump Threatens To Slam Pharmaceuticals With Up To 200% Tariffs ↗

July 08, 2025

President Donald Trump threatened Tuesday to levy up to 200% tariffs on drugs imported into the U.S. "very soon."

Via Investor's Business Daily

Topics ETFs Economy Government

US Supreme Court Reportedly Upholds Part Of Obamacare That Guarantees Health Insurers Cover Preventive Care ↗

June 27, 2025

The Obamacare law requires health insurers to provide preventive care, including cancer screenings and HIV prevention medication, at no cost to patients.

Via Stocktwits

Topics Government Lawsuit Religion

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment ↗

May 19, 2025

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

Via Benzinga

Trump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security Concerns ↗

May 06, 2025

President Donald Trump signed an executive order Monday directing the FDA to accelerate approvals for domestic pharmaceutical manufacturing facilities as his administration prepares to announce new...

Via Benzinga

Topics Government World Trade

Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗

April 28, 2025

Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...

Via Talk Markets

Topics ETFs Stocks / Equities

The Major Sector ETFs Got Their Story ↗

April 27, 2025

XRT has more work to do. At best, the consumer sector is trying to bottom. At worst, this is a rally into resistance.

Via Talk Markets

Topics ETFs

< Previous 1 2 3 4 5 6 7 8 9

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.